171 related articles for article (PubMed ID: 20109112)
1. Proteome analysis of schizophrenia brain tissue.
Martins-De-Souza D; Dias-Neto E; Schmitt A; Falkai P; Gormanns P; Maccarrone G; Turck CW; Gattaz WF
World J Biol Psychiatry; 2010 Mar; 11(2):110-20. PubMed ID: 20109112
[TBL] [Abstract][Full Text] [Related]
2. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.
Martins-de-Souza D; Maccarrone G; Wobrock T; Zerr I; Gormanns P; Reckow S; Falkai P; Schmitt A; Turck CW
J Psychiatr Res; 2010 Dec; 44(16):1176-89. PubMed ID: 20471030
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia.
Martins-de-Souza D; Gattaz WF; Schmitt A; Maccarrone G; Hunyadi-Gulyás E; Eberlin MN; Souza GH; Marangoni S; Novello JC; Turck CW; Dias-Neto E
J Psychiatr Res; 2009 Jul; 43(11):978-86. PubMed ID: 19110265
[TBL] [Abstract][Full Text] [Related]
5. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
6. Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia.
Martins-de-Souza D; Schmitt A; Röder R; Lebar M; Schneider-Axmann T; Falkai P; Turck CW
J Psychiatr Res; 2010 Oct; 44(14):989-91. PubMed ID: 20381070
[TBL] [Abstract][Full Text] [Related]
7. 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease.
English JA; Dicker P; Föcking M; Dunn MJ; Cotter DR
Proteomics; 2009 Jun; 9(12):3368-82. PubMed ID: 19562803
[TBL] [Abstract][Full Text] [Related]
8. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia.
Pennington K; Dicker P; Dunn MJ; Cotter DR
Proteomics; 2008 Dec; 8(23-24):5097-107. PubMed ID: 19003868
[TBL] [Abstract][Full Text] [Related]
10. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia.
Clark D; Dedova I; Cordwell S; Matsumoto I
Mol Psychiatry; 2006 May; 11(5):459-70, 423. PubMed ID: 16491132
[TBL] [Abstract][Full Text] [Related]
11. Exercise affects energy metabolism and neural plasticity-related proteins in the hippocampus as revealed by proteomic analysis.
Ding Q; Vaynman S; Souda P; Whitelegge JP; Gomez-Pinilla F
Eur J Neurosci; 2006 Sep; 24(5):1265-76. PubMed ID: 16987214
[TBL] [Abstract][Full Text] [Related]
12. RNA metabolism and dysmyelination in schizophrenia.
McInnes LA; Lauriat TL
Neurosci Biobehav Rev; 2006; 30(4):551-61. PubMed ID: 16445981
[TBL] [Abstract][Full Text] [Related]
13. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.
Huang JT; Wang L; Prabakaran S; Wengenroth M; Lockstone HE; Koethe D; Gerth CW; Gross S; Schreiber D; Lilley K; Wayland M; Oxley D; Leweke FM; Bahn S
Mol Psychiatry; 2008 Dec; 13(12):1118-28. PubMed ID: 17938634
[TBL] [Abstract][Full Text] [Related]
14. Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention deficit hyperactivity disorder (ADHD) research.
Hirano M; Rakwal R; Shibato J; Sawa H; Nagashima K; Ogawa Y; Yoshida Y; Iwahashi H; Niki E; Masuo Y
J Proteome Res; 2008 Jun; 7(6):2471-89. PubMed ID: 18457438
[TBL] [Abstract][Full Text] [Related]
15. Proteome analysis of mouse primary astrocytes.
Yang JW; Suder P; Silberring J; Lubec G
Neurochem Int; 2005 Aug; 47(3):159-72. PubMed ID: 15908045
[TBL] [Abstract][Full Text] [Related]
16. High-performance proteomics as a tool in biomarker discovery.
Meyer HE; Stühler K
Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
[TBL] [Abstract][Full Text] [Related]
17. Alterations in rat serum proteome and metabolome as putative disease markers in sepsis.
Hinkelbein J; Feldmann RE; Schubert C; Peterka A; Schelshorn D; Maurer MH; Kalenka A
J Trauma; 2009 Apr; 66(4):1065-75. PubMed ID: 19359916
[TBL] [Abstract][Full Text] [Related]
18. Proteomic identification of salivary biomarkers of type-2 diabetes.
Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
[TBL] [Abstract][Full Text] [Related]
19. 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia.
Prabakaran S; Wengenroth M; Lockstone HE; Lilley K; Leweke FM; Bahn S
J Proteome Res; 2007 Jan; 6(1):141-9. PubMed ID: 17203958
[TBL] [Abstract][Full Text] [Related]
20. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.
Casado B; Iadarola P; Luisetti M; Kussmann M
Expert Rev Proteomics; 2008 Oct; 5(5):693-704. PubMed ID: 18937559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
